SwePub
Sök i LIBRIS databas

  Extended search

id:"swepub:oai:DiVA.org:liu-43522"
 

Search: id:"swepub:oai:DiVA.org:liu-43522" > GLP-1 suppresses ga...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist
  • Hellström, P. M.Department of Medicine Karolinska Institutet, Stockholm (author)

GLP-1 suppresses gastrointestinal motility and inhibits the migrating motor complex in healthy subjects and patients with irritable bowel syndrome

  • Article/chapterEnglish2008

Publisher, publication year, extent ...

  • Wiley,2008
  • printrdacarrier

Numbers

  • LIBRIS-ID:oai:DiVA.org:liu-43522
  • https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-43522URI
  • https://doi.org/10.1111/j.1365-2982.2007.01079.xDOI
  • http://kipublications.ki.se/Default.aspx?queryparsed=id:117031750URI

Supplementary language notes

  • Language:English
  • Summary in:English

Part of subdatabase

Classification

  • Subject category:ref swepub-contenttype
  • Subject category:art swepub-publicationtype

Notes

  • Glucagon-like peptide-1 (GLP-1) is released after food intake to act as an incretin. GLP-1 also inhibits gastric emptying and increases satiety. In rats, GLP-1 inhibits small bowel motility. Our aim was to study the effects of GLP-1 on gastrointestinal motility in healthy subjects and patients with irritable bowel syndrome (IBS). Antro-duodeno-jejunal manometry was carried out during a 4-h control period with saline, followed by a 4-h period with intravenous GLP-1 (healthy: 0.7 and 1.2 pmol kg-1 min-1 (n = 16), IBS, 1.2 and 2.5 pmol kg-1 min-1 (n = 14). Plasma was analysed for GLP-1 and gut hormones, and gut tissue expression of GLP-1 receptor was studied. In healthy subjects, GLP-1 0.7 pmol kg-1 min-1 reduced the migrating motor complexes (MMCs) from a median of 2 (range 2-3) to 0.5 (0-2), and motility index from 4.9 ± 0.1 to 4.3 ± 0.3 ln ∑(mmHg*s min-1) in jejunum, while GLP-1 1.2 pmol kg -1 min-1 diminshed MMCs from 2 (2-3) to 1.5 (1-2.5), and motility index from 5.2 ± 0.2 to 4.4 ± 0.2. In IBS patients, GLP-1 1.2 pmol kg-1 min-1 reduced the MMCs from 2.5 (2-3.5) to 1 (0-1.5) without affecting motility index. At 2.5 pmol kg-1 min -1 GLP-1 decreased MMCs from 2 (1.5-3) to 1 (0.5-1.5), and motility index from 5.2 ± 0.2 to 4.0 ± 0.5. Motility responses to GLP-1 were similar in antrum and duodenum. Presence of the GLP-1 receptor in the gut was verified by reverse transcriptase PCR. In conclusion, the gut peptide GLP-1 decreases motility in the antro-duodeno-jejunal region and inhibits the MMC in healthy subjects and IBS patients. © 2008 The Authors.

Subject headings and genre

  • MEDICINE
  • MEDICIN

Added entries (persons, corporate bodies, meetings, titles ...)

  • Näslund, E.Karolinska Institutet (author)
  • Edholm, T.Department of Medicine Karolinska Institutet, Stockholm (author)
  • Schmidt, P. T.Karolinska Institutet (author)
  • Kristensen, J.Department of Medicine Karolinska Institutet, Stockholm (author)
  • Theodorsson, Elvar,1953-Östergötlands Läns Landsting,Linköpings universitet,Hälsouniversitetet,Klinisk kemi(Swepub:liu)elvth65 (author)
  • Holst, J. J.§Department of Medical Physiology University of Copenhagen, Denmark (author)
  • Efendic, S.Department of Molecular Medicine and Surgery Karolinska Institutet, Stockholm (author)
  • Karolinska InstitutetDepartment of Medicine Karolinska Institutet, Stockholm (creator_code:org_t)

Related titles

  • In:Neurogastroenterology and Motility: Wiley20:6, s. 649-6591350-19251365-2982

Internet link

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view